image
Healthcare - Medical - Devices - NASDAQ - US
$ 9.34
-1.37 %
$ 259 M
Market Cap
-7.59
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one ZIMV stock under the worst case scenario is HIDDEN Compared to the current market price of 9.34 USD, ZimVie Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one ZIMV stock under the base case scenario is HIDDEN Compared to the current market price of 9.34 USD, ZimVie Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one ZIMV stock under the best case scenario is HIDDEN Compared to the current market price of 9.34 USD, ZimVie Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart ZIMV

image
$16.0$16.0$15.0$15.0$14.0$14.0$13.0$13.0$12.0$12.0$11.0$11.0$10.0$10.0$9.0$9.015 Oct15 OctNov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '25
FINANCIALS
450 M REVENUE
-1.68%
-20.7 M OPERATING INCOME
33.21%
-25.8 M NET INCOME
93.43%
14.2 M OPERATING CASH FLOW
-61.84%
282 M INVESTING CASH FLOW
1960.39%
-295 M FINANCING CASH FLOW
-1048.08%
112 M REVENUE
8.04%
-6.33 M OPERATING INCOME
-107.68%
-11.8 M NET INCOME
-415.15%
21.4 M OPERATING CASH FLOW
1688.99%
-2.87 M INVESTING CASH FLOW
-442.08%
776 K FINANCING CASH FLOW
104.13%
Balance Sheet ZimVie Inc.
image
Current Assets 257 M
Cash & Short-Term Investments 75 M
Receivables 65.2 M
Other Current Assets 117 M
Non-Current Assets 496 M
Long-Term Investments 0
PP&E 47.3 M
Other Non-Current Assets 449 M
9.95 %8.65 %15.54 %6.27 %59.59 %Total Assets$753.7m
Current Liabilities 134 M
Accounts Payable 33 M
Short-Term Debt 3.9 M
Other Current Liabilities 97.1 M
Non-Current Liabilities 238 M
Long-Term Debt 229 M
Other Non-Current Liabilities 9.35 M
8.86 %26.10 %61.48 %Total Liabilities$372.0m
EFFICIENCY
Earnings Waterfall ZimVie Inc.
image
Revenue 450 M
Cost Of Revenue 162 M
Gross Profit 287 M
Operating Expenses 308 M
Operating Income -20.7 M
Other Expenses 5.16 M
Net Income -25.8 M
450m450m400m400m350m350m300m300m250m250m200m200m150m150m100m100m50m50m00(50m)(50m)450m(162m)287m(308m)(21m)(5m)(26m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
63.91% GROSS MARGIN
63.91%
-4.59% OPERATING MARGIN
-4.59%
-2.97% NET MARGIN
-2.97%
-3.50% ROE
-3.50%
-1.77% ROA
-1.77%
-1.88% ROIC
-1.88%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis ZimVie Inc.
image
120m120m100m100m80m80m60m60m40m40m20m20m00(20m)(20m)20192019202020202021202120222022202320232024202420252025
Net Income -25.8 M
Depreciation & Amortization 34.3 M
Capital Expenditures -6.68 M
Stock-Based Compensation 16.6 M
Change in Working Capital 0
Others -6.66 M
Free Cash Flow 7.49 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets ZimVie Inc.
image
Wall Street analysts predict an average 1-year price target for ZIMV of $20 , with forecasts ranging from a low of $20 to a high of $20 .
ZIMV Lowest Price Target Wall Street Target
20 USD 114.13%
ZIMV Average Price Target Wall Street Target
20 USD 114.13%
ZIMV Highest Price Target Wall Street Target
20 USD 114.13%
Price
Max Price Target
Min Price Target
Average Price Target
222220201818161614141212101088May '24May '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 15
6. Ownership
Insider Ownership ZimVie Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
9.3 M USD 1
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
ZimVie to Participate in the 24th Annual Needham Virtual Healthcare Conference PALM BEACH GARDENS, Fla., March 25, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced management will participate in the upcoming 24th Annual Needham Virtual Healthcare Conference. Management will be presenting on Tuesday, April 8, 2025 at 3:00 p.m. Eastern Time / 12:00 p.m. Pacific Time. globenewswire.com - 2 weeks ago
ZimVie Announces Upcoming Changes to Company's Board of Directors PALM BEACH GARDENS, Fla., March 13, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced upcoming changes to the Company's Board of Directors, including: globenewswire.com - 1 month ago
Dental Players Dentsply Sirona, ZimVie Show Weak Growth Outlook: Analyst Dentsply Sirona  XRAY and ZimVie Inc. ZIMV show below-market growth and have no meaningful upside, according Needham analysts. benzinga.com - 1 month ago
ZimVie Inc. (ZIMV) Q4 2024 Earnings Call Transcript ZimVie Inc. (NASDAQ:ZIMV ) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants Marissa Bych - Investor Relations Vafa Jamali - President & Chief Executive Officer Richard Heppenstall - Chief Financial Officer Conference Call Participants David Saxon - Needham & Company Kevin Caliendo - UBS William McMahon - Barclays Operator Good afternoon and welcome to ZimVie's Fourth Quarter 2024 Earnings Conference Call. Currently, all participants are in a listen-only mode. seekingalpha.com - 1 month ago
ZimVie Reports Fourth Quarter and Full Year 2024 Financial Results PALM BEACH GARDENS, Fla., Feb. 26, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today reported financial results for the quarter and year ended December 31, 2024. Management will host a corresponding conference call today, February 26, 2025, at 4:30 p.m. Eastern Time. globenewswire.com - 1 month ago
ZimVie to Report Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025 PALM BEACH GARDENS, Fla., Feb. 12, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced it will report financial results for the fourth quarter and full-year 2024 after market close on Wednesday, February 26, 2025. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. globenewswire.com - 1 month ago
ZimVie Announces Publication of a Study Supporting the Benefits of Its Implant Surface Technologies Data confirms ZimVie implants meet critical roughness criteria advantageous for long-term peri-implant health Data confirms ZimVie implants meet critical roughness criteria advantageous for long-term peri-implant health globenewswire.com - 2 months ago
ZimVie Inc. (ZIMV) Q3 2024 Earnings Call Transcript ZimVie Inc. (NASDAQ:ZIMV ) Q3 2024 Results Conference Call October 30, 2024 4:30 PM ET Company Participants Marissa Bych - IR, Gilmartin Group LLC Vafa Jamali - President and CEO Richard Heppenstall - CFO Conference Call Participants David Saxon - Needham & Company Matt Miksic - Barclays Marissa Bych Thank you all for joining today's call. Earlier today, ZimVie released financial results for the quarter ended September 30, 2024. seekingalpha.com - 5 months ago
ZimVie to Report Third Quarter Financial Results on October 30, 2024 PALM BEACH GARDENS, Fla., Oct. 16, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced it will report financial results for the third quarter 2024 after market close on Wednesday, October 30, 2024. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. globenewswire.com - 5 months ago
Mexico Spinal Implants Market Size, Share & Trends Analysis 2024-2030, with Focus on Market Leaders ZimVie/Highridge Medical, Medtronic and DePuy Synthes Dublin, Oct. 02, 2024 (GLOBE NEWSWIRE) -- The "Mexico Spinal Implants Market Size, Share & Trends Analysis | 2024-2030 | MedSuite | Includes: Cervical Fixation Market, Thoracolumbar Fixation Market, and 4 more" report has been added to ResearchAndMarkets.com's offering. In 2023, Mexico's spinal implant and VCF market reached a valuation exceeding $135 million. Projected to grow at a CAGR of 6.1%, the market is expected to surpass $205 million by 2030. This comprehensive report on the Mexican spinal implant and VCF market covers various segments, including traditional cervical and thoracolumbar fixation devices, interbody devices, motion preservation devices, VCF treatment, electrical stimulation devices, and spinal surgery instrumentation. Key Market Data Insights: globenewswire.com - 6 months ago
ZimVie Inc. (ZIMV) Q2 2024 Earnings Call Transcript ZimVie Inc. (NASDAQ:ZIMV ) Q2 2024 Earnings Conference Call August 1, 2024 4:30 AM ET Company Participants Marissa Bych - IR, Gilmartin Group LLC Vafa Jamali - President and CEO Richard Heppenstall - CFO Conference Call Participants David Saxon - Needham & Company Matt Miksic - Barclays Operator Good afternoon, and welcome to ZimVie's Second Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded for replay purposes. seekingalpha.com - 8 months ago
ZimVie Announces FDA Clearance and U.S. Launch of GenTek® Restorative Components Addition of Premium Restorative Components Enhances ZimVie's End-to-End Implant Offerings Addition of Premium Restorative Components Enhances ZimVie's End-to-End Implant Offerings globenewswire.com - 8 months ago
8. Profile Summary

ZimVie Inc. ZIMV

image
COUNTRY US
INDUSTRY Medical - Devices
MARKET CAP $ 259 M
Dividend Yield 0.00%
Description ZimVie Inc., a medical technology company, develops, manufactures, and delivers a portfolio of products and solutions designed to treat a range of spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; bone grafts, barrier membranes, allografts, and collagen wound care products; intraoral scanners; and virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and patient-specific restorative components and intra-oral scanners, as well as spinal fusion implants and instrumentation for various spinal procedures, biologics, and bone healing technologies. The company also provides MIS solutions, such as Vital MIS and Timberline; and motion preservation solutions, including Mobi-C and The Tether. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.
Contact 10225 Westmoor Drive, Westminster, CO, 80021 https://www.zimvie.com
IPO Date Feb. 16, 2022
Employees 1770
Officers Mr. Vafa Jamali President, Chief Executive Officer & Director Sandra Schneider Chief Accounting Officer Mr. Richard J. Heppenstall Executive Vice President, Chief Financial Officer & Treasurer Mr. Indraneel Kanaglekar Senior Vice President & Chief Commercial Officer Ms. Heather Kidwell Senior Vice President, Chief Legal, HR & Compliance Officer and Corporate Secretary Mr. Steve Rondeau Senior Vice President & Chief Information Officer